Search details
1.
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study.
Blood
; 142(16): 1348-1358, 2023 10 19.
Article
in English
| MEDLINE | ID: mdl-37369099
2.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Article
in English
| MEDLINE | ID: mdl-32877583
3.
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
Clin Lung Cancer
; 24(7): 641-650.e2, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37741716
4.
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.
Anticancer Drugs
; 20(7): 634-8, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19433978
5.
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer.
Eur J Cancer
; 89: 27-35, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29223479
Results
1 -
5
de 5
1
Next >
>>